<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04346459</url>
  </required_header>
  <id_info>
    <org_study_id>11/11/2019anesthesia</org_study_id>
    <nct_id>NCT04346459</nct_id>
  </id_info>
  <brief_title>Three Different Techniques for Tracheal Intubation Via Supraglottic Airway Devices</brief_title>
  <official_title>Evaluation of Three Different Techniques for Tracheal Intubation Via Supraglottic Airway Devices: A Comparative Randomised Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Patras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Patras</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares three different supraglottic airway devices used as a conduit for&#xD;
      tracheal intubation in order το determine which one achieves the highest success rate of&#xD;
      first attempt intubation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, randomized, comparative, clinical, controlled study, that is approved by the&#xD;
      Ethics Commitee of the University of Patras (10.12.2019) and takes part in the University&#xD;
      Hospital of Patras. Depending on the supraglottic airway device (SGA)/ laryngeal mask airway&#xD;
      (LMA) used to achieve intubation (Fastrach, I-gel, Protector), partcipants will be randomly&#xD;
      allocated into three groups; Group A, B and C (Fastrach, I-gel, Protector respectively).&#xD;
&#xD;
      In the preoperative setting, a complete preanesthetic evaluation will be performed, including&#xD;
      a detailed airway assessment (prediction of difficulty in face mask ventilation, insertion of&#xD;
      SGA/LMA and intubation).&#xD;
&#xD;
      All patients are scheduled to undergo an elective surgery under general anesthesia. Before&#xD;
      induction, all patients will be preoxygenated with FiO2 100% for at least 5 minutes. After&#xD;
      induction, using rocuronium 0.6mg/kg to facilitate neuromuscular blockade, face mask&#xD;
      ventilation follows.&#xD;
&#xD;
        1. Group A- Fastrach: The intubating laryngeal mask airway (Fastrach) will be placed to the&#xD;
           patients of this group. After the mask is correctly placed and patients are adequately&#xD;
           ventilated, they will be intubated through the mask using its own endotracheal tube&#xD;
           according to the blind technique insertion.&#xD;
&#xD;
        2. Group B- I-gel: The supraglottic airway device (I-gel) will be placed to the patients of&#xD;
           this group. After the mask is correctly placed and patients are adequately ventilated,&#xD;
           they will be intubated through the mask using a fiberoptic bronchoscope to guide&#xD;
           endotracheal tube's placement.&#xD;
&#xD;
        3. Group C- Protector: The supraglottic airway device (Protector) will be placed to the&#xD;
           patients of this group. After the mask is correctly placed and patients are adequately&#xD;
           ventilated, they will be intubated through the mask using a fiberoptic bronchoscope to&#xD;
           guide endotracheal tube's placement.&#xD;
&#xD;
      In all groups (A, B, C) up to 3 attempts of SGA/LMA placement and up to 3 attempts of&#xD;
      intubation are allowed to be made.&#xD;
&#xD;
      In case of an emerging unpredicted difficult airway and a concurrent unsuccessful SGA/LMA&#xD;
      placement, then the algorithm of the difficult airway will be immediately followed.&#xD;
      Video-assisted laryngoscopy will be the first option rescue alternative.&#xD;
&#xD;
      The time of the whole procedure from the beginning of SGA's/LMA's placement effort until the&#xD;
      successful intubation will be recorded, along with the evaluation of the success rate of&#xD;
      first intubation attempt.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2020</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate of intubation at first attempt</measure>
    <time_frame>Up to study completion, an average of 2 years</time_frame>
    <description>Recording of successful tracheal intubation at first attempt (yes/no) and evaluation of the success rate at first attempt</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time required for tracheal intubation</measure>
    <time_frame>Up to study completion, an average of 2 years</time_frame>
    <description>Time required from the beginning of the insertion of the supraglottic airway device/ laryngeal mask until the endotracheal tube is successfully placed confirmed by continuous waveform capnography (3 cycles)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time required for successful supraglottic airway device/ laryngeal mask placement</measure>
    <time_frame>Up to study completion, an average of 2 years</time_frame>
    <description>Time required from the beginning of the insertion of the supraglottic airway device/ laryngeal mask until adequate ventilation is confirmed by continuous waveform capnography (3 cycles)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Tracheal Intubation</condition>
  <arm_group>
    <arm_group_label>Group A- Fastrach (control group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of 40 patients scheduled for elective surgery under general anesthesia are planned to be intubated using intubating laryngeal mask airway &quot;Fastrach&quot; following blind intubating method through &quot;Fastrach&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B- I-gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of 40 patients scheduled for elective surgery under general anesthesia are planned to be intubated using &quot;I-gel&quot; supraglottic airway device as a conduit for tracheal intubation guided by a fiberoptic bronchoscope.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C- Protector</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of 40 patients scheduled for elective surgery under general anesthesia are planned to be intubated using the &quot;Protector&quot; laryngeal mask airway as a conduit for tracheal intubation guided by a fiberoptic bronchoscope.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tracheal intubation through &quot;Fastrach&quot; - Group A</intervention_name>
    <description>Insertion of the intubating laryngeal mask &quot;Fastrach&quot; and blind tracheal intubation through the device</description>
    <arm_group_label>Group A- Fastrach (control group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tracheal intubation through &quot;I-gel&quot; - Group B</intervention_name>
    <description>Insertion of the supraglottic airway device &quot;i-gel&quot; and tracheal intubation through the device guided by a fiberoptic bronchoscope</description>
    <arm_group_label>Group B- I-gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tracheal intubation through &quot;Protector&quot; - Group C</intervention_name>
    <description>Insertion of the laryngeal mask &quot;Protector&quot; and tracheal intubation through the device guided by a fiberoptic bronchoscope</description>
    <arm_group_label>Group C- Protector</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients (age ≥ 18 yrs) scheduled for an elective surgery under general anesthesia&#xD;
&#xD;
          -  Written informed consent to participate in the trial&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 yrs&#xD;
&#xD;
          -  Non- elective (urgent/ emergency) procedures or multi-trauma patients&#xD;
&#xD;
          -  Obstetric population&#xD;
&#xD;
          -  Surgery performed under regional anesthesia&#xD;
&#xD;
          -  Contraindication to LMA insertion&#xD;
&#xD;
          -  Predicted difficulty in LMA insertion (at least one out of four &quot;RODS&quot; criteria)&#xD;
&#xD;
          -  Contraindication to the use of neuromuscular blockade or situations that require&#xD;
             spontaneous breathing&#xD;
&#xD;
          -  Indication for awake intubation or surgical airway&#xD;
&#xD;
          -  Patients' involvement in another clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregorios Voyagis, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Patras, Department of Anesthesiology and Critical Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Spyraki, MSc</last_name>
    <phone>6944471259</phone>
    <phone_ext>0030</phone_ext>
    <email>maria.uop@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Georgios Karpetas, MSc</last_name>
    <phone>6993704130</phone>
    <phone_ext>0030</phone_ext>
    <email>giokar8@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Patras</name>
      <address>
        <city>Patras</city>
        <state>Achaia</state>
        <zip>26500</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregorios Voyagis, MD, PhD</last_name>
      <phone>2610999221</phone>
      <phone_ext>0030</phone_ext>
      <email>gsvgasman@yahoo.gr</email>
    </contact>
    <contact_backup>
      <last_name>Maria Spyraki, MSc</last_name>
      <phone>6944471259</phone>
      <phone_ext>0030</phone_ext>
      <email>maria.uop@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 10, 2020</study_first_submitted>
  <study_first_submitted_qc>April 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>April 14, 2020</last_update_submitted>
  <last_update_submitted_qc>April 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Patras</investigator_affiliation>
    <investigator_full_name>Maria Spyraki</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>tracheal intubation</keyword>
  <keyword>supraglottic airway device</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

